It is estimated that millions of people across all ages were affected by this disease, and an increasing trend in incidence and prevalence has been observed worldwide over these years ( Kobayashi et al., 2020 ).
← all excerpts
Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials.
1
—
—